Takabe, H.; Warnken, Z.N.; Zhang, Y.; Davis, D.A.; Smyth, H.D.C.; Kuhn, J.G.; Weitman, S.; Williams III, R.O.
A Repurposed Drug for Brain Cancer: Enhanced Atovaquone Amorphous Solid Dispersion by Combining a Spontaneously Emulsifying Component with a Polymer Carrier. Pharmaceutics 2018, 10, 60.
https://doi.org/10.3390/pharmaceutics10020060
AMA Style
Takabe H, Warnken ZN, Zhang Y, Davis DA, Smyth HDC, Kuhn JG, Weitman S, Williams III RO.
A Repurposed Drug for Brain Cancer: Enhanced Atovaquone Amorphous Solid Dispersion by Combining a Spontaneously Emulsifying Component with a Polymer Carrier. Pharmaceutics. 2018; 10(2):60.
https://doi.org/10.3390/pharmaceutics10020060
Chicago/Turabian Style
Takabe, Hiroyuki, Zachary N. Warnken, Yajie Zhang, Daniel A. Davis, Hugh D. C. Smyth, John G. Kuhn, Steve Weitman, and Robert O. Williams III.
2018. "A Repurposed Drug for Brain Cancer: Enhanced Atovaquone Amorphous Solid Dispersion by Combining a Spontaneously Emulsifying Component with a Polymer Carrier" Pharmaceutics 10, no. 2: 60.
https://doi.org/10.3390/pharmaceutics10020060
APA Style
Takabe, H., Warnken, Z. N., Zhang, Y., Davis, D. A., Smyth, H. D. C., Kuhn, J. G., Weitman, S., & Williams III, R. O.
(2018). A Repurposed Drug for Brain Cancer: Enhanced Atovaquone Amorphous Solid Dispersion by Combining a Spontaneously Emulsifying Component with a Polymer Carrier. Pharmaceutics, 10(2), 60.
https://doi.org/10.3390/pharmaceutics10020060